Nucleic Acid Electrophoresis,
RNA Isolation & Purification
Invitrogen, part of Life Technologies Corporation, introduced two reagent solutions to simplify genomic and transcriptome analysis on next-generation, high-throughput genomic analysis platforms. The RiboMinus kit and the E-Gel SizeSelect 2% pre-cast agarose gels are designed to simplify workflows and reduce the experimental time and cost of applications such as discovery and characterization of the entire transcriptome, validation of whole genome association results, targeted resequencing, chromatin immunoprecipitation (ChIP), rare and somatic mutation detection, and epigenetic studies. The solutions are compatible with next-generation high-throughput genome analysis platforms, including Life Technologies’ Applied Biosystems SOLiD System, Illumina’s Genome Analyzer, and Roche’s Genome Sequencer FLX System. The RiboMinus for RNA-sequencing kits are available in two configurations: a universal kit for eukaryotes and a more specialized kit for plants. The E-Gel SizeSelect 2% pre-cast agarose gels are designed to simplify the separation and recovery of nucleic acid fragments of less than 1000 base pairs for short read fragment library construction.
This Product is made by:
Life Technologies (NASDAQ: LIFE) is a global biotechnology tools company
dedicated to improving the human condition. The company's systems,
consumables and services enable researchers to accelerate scientific
exploration, driving to discoveries and developments that make life even
better. Life Technologies customers do their work across the biological
spectrum, working to advance personalized medicine, regenerative science,
molecular diagnostics, agricultural and environmental research, and 21st
century forensics. The company has historical sales of approximately $3.5
billion, employs 9,500 people, has a presence in more than 100 countries,
and possesses a rapidly growing intellectual property estate of over 3,600
patents and exclusive licenses. Life Technologies was created by the
combination of Invitrogen Corporation and Applied Biosystems Inc.